AVANIR PHARMACEUTICALS, INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2014 12 months to Sep 30, 2014	FY2013 12 months to Sep 30, 2013	FY2012 12 months to Sep 30, 2012	FY2011 12 months to Sep 30, 2011
Gross product sales
Less: discount and allowances
Revenues:
Net product sales
Revenues from royalties
Other revenues
Other revenue gross margin
Total gross margin
Revenues from co-promote activities
Revenues from research grant services
Total revenues

Operating expenses:
Cost of product sales
Product gross margin (loss)
Cost of research grant services
Research and development
Selling, general and administrative
Selling and marketing
General and administrative
Total selling, general and administrative
Total operating expenses

Loss from operations
Other income (expense):
Interest income
Interest expense
Loss on early extinguishment of debt
Other, net
Loss before provision for income taxes
Provision for income taxes
Net loss
Basic and diluted net loss per share
Basic and diluted weighted average number of common shares outstanding

Comments